• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钌 II(η6-芳基)硫脲衍生物配合物的合成、表征及脲酶抑制作用。

RutheniumII(η6-arene) complexes of thiourea derivatives: synthesis, characterization and urease inhibition.

机构信息

School of Chemical Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand.

Department of Chemistry, COMSATS Institute of Information Technology, Abbottabad 22060, Pakistan.

出版信息

Molecules. 2014 Jun 16;19(6):8080-92. doi: 10.3390/molecules19068080.

DOI:10.3390/molecules19068080
PMID:24936709
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6271941/
Abstract

RuII(arene) complexes have emerged as a versatile class of compounds to design metallodrugs as potential treatment for a wide range of diseases including cancer and malaria. They feature modes of action that involve classic DNA binding like platinum anticancer drugs, may covalent binding to proteins, or multimodal biological activity. Herein, we report the synthesis and urease inhibition activity of RuII(arene) complexes of the general formula [RuII(η6-p-cymene)(L)Cl2] and [RuII(η6-p-cymene)(PPh3)(L)Cl]PF6 with S-donor systems (L) based on heterocyclic thiourea derivatives. The compounds were characterized by 1H-, 13C{1H}- and 31P{1H}-NMR spectroscopy, as well as elemental analysis. The crystal structure of [chlorido(η6-p-cymene)(imidazolidine-2-thione)(triphenylphosphine)ruthenium(II)] hexafluorophosphate 11 was determined by X-ray diffraction analysis. A signal in the range 175-183 ppm in the 13C{1H}-NMR spectrum indicates the presence of a thione rather than a thiolate. This observation was also confirmed in the solid state by X-ray diffraction analysis of 11 which shows a C=S bond length of 1.720 Å. The compounds were tested for urease inhibitory activity and the thiourea-derived ligands exhibited moderate activity, whereas their corresponding Ru(arene) complexes were not active.

摘要

RuII(芳基)配合物已成为一类多功能化合物,可用于设计金属药物,作为治疗多种疾病(包括癌症和疟疾)的潜在方法。它们具有与经典 DNA 结合的作用模式,如铂类抗癌药物,可能与蛋白质发生共价结合,或具有多种模式的生物活性。在此,我们报告了通用式[RuII(η6-p-cymene)(L)Cl2]和[RuII(η6-p-cymene)(PPh3)(L)Cl]PF6的 RuII(芳基)配合物的合成及其对脲酶的抑制活性,其中 L 是基于杂环硫脲衍生物的 S 供体系统。这些化合物通过 1H-、13C{1H}-和 31P{1H}-NMR 光谱以及元素分析进行了表征。通过 X 射线衍射分析确定了[氯(η6-p-cymene)(咪唑烷-2-硫酮)(三苯基膦)钌(II)]六氟磷酸盐 11 的晶体结构。13C{1H}-NMR 光谱中 175-183 ppm 范围内的信号表明存在硫酮而不是硫醇。这一观察结果也通过 11 的 X 射线衍射分析得到了证实,其中 C=S 键长为 1.720 Å。对这些化合物进行了脲酶抑制活性测试,结果表明硫脲衍生配体具有中等活性,而其相应的 Ru(芳基)配合物则没有活性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/683b/6271941/dc739ff67067/molecules-19-08080-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/683b/6271941/bb3e5478bea9/molecules-19-08080-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/683b/6271941/51a1aee9a5d8/molecules-19-08080-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/683b/6271941/dc739ff67067/molecules-19-08080-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/683b/6271941/bb3e5478bea9/molecules-19-08080-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/683b/6271941/51a1aee9a5d8/molecules-19-08080-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/683b/6271941/dc739ff67067/molecules-19-08080-g002.jpg

相似文献

1
RutheniumII(η6-arene) complexes of thiourea derivatives: synthesis, characterization and urease inhibition.钌 II(η6-芳基)硫脲衍生物配合物的合成、表征及脲酶抑制作用。
Molecules. 2014 Jun 16;19(6):8080-92. doi: 10.3390/molecules19068080.
2
Synthesis, characterization, and in vitro evaluation of novel ruthenium(II) eta6-arene imidazole complexes.新型钌(II)η6 - 芳烃咪唑配合物的合成、表征及体外评价
J Med Chem. 2006 Sep 7;49(18):5552-61. doi: 10.1021/jm060495o.
3
Structure-activity relationships of targeted RuII(η6-p-cymene) anticancer complexes with flavonol-derived ligands.靶向 RuII(η6-p-cymene)抗癌配合物与黄酮醇衍生配体的构效关系。
J Med Chem. 2012 Dec 13;55(23):10512-22. doi: 10.1021/jm301376a. Epub 2012 Nov 19.
4
Synthesis, characterization, antimicrobial and cytotoxic activity of novel half-sandwich Ru(II) arene complexes with benzoylthiourea derivatives.新型苯甲酰基硫脲衍生物半夹心钌(II)芳基配合物的合成、表征、抗菌和细胞毒性活性。
J Inorg Biochem. 2020 Sep;210:111164. doi: 10.1016/j.jinorgbio.2020.111164. Epub 2020 Jun 26.
5
Discovery of high in vitro and in vivo antitumor activities of organometallic ruthenium(ii)-arene complexes with 5,7-dihalogenated-2-methyl-8-quinolinol.发现含5,7-二卤代-2-甲基-8-喹啉醇的有机金属钌(II)-芳烃配合物具有高体外和体内抗肿瘤活性。
Dalton Trans. 2019 Apr 16;48(16):5352-5360. doi: 10.1039/c9dt00866g.
6
Phenylazo-pyridine and phenylazo-pyrazole chlorido ruthenium(II) arene complexes: arene loss, aquation, and cancer cell cytotoxicity.苯基偶氮吡啶和苯基偶氮吡唑氯钌(II)芳烃配合物:芳烃损失、水合作用及癌细胞细胞毒性
Inorg Chem. 2006 Dec 25;45(26):10882-94. doi: 10.1021/ic061460h.
7
Chloro half-sandwich osmium(II) complexes: influence of chelated N,N-ligands on hydrolysis, guanine binding, and cytotoxicity.氯半夹心钌(II)配合物:螯合的N,N-配体对水解、鸟嘌呤结合及细胞毒性的影响。
Inorg Chem. 2007 May 14;46(10):4049-59. doi: 10.1021/ic062350d. Epub 2007 Apr 19.
8
Synthesis, in vitro urease inhibitory activity, and molecular docking studies of thiourea and urea derivatives.硫脲和脲衍生物的合成、体外脲酶抑制活性及分子对接研究。
Bioorg Chem. 2018 Oct;80:129-144. doi: 10.1016/j.bioorg.2018.06.007. Epub 2018 Jun 5.
9
Derivation of structure-activity relationships from the anticancer properties of ruthenium(II) arene complexes with 2-aryldiazole ligands.基于钌(II)芳烃配合物与2-芳基二唑配体的抗癌特性推导构效关系
Inorg Chem. 2014 Oct 20;53(20):11274-88. doi: 10.1021/ic501865h. Epub 2014 Oct 10.
10
1,3,4-Thiadiazole and 1,2,4-triazole-5-thione derivatives bearing 2-pentyl-5-phenyl-2,4-dihydro-3H-1,2,4-triazole-3-one ring: Synthesis, molecular docking, urease inhibition, and crystal structure.含2-戊基-5-苯基-2,4-二氢-3H-1,2,4-三唑-3-酮环的1,3,4-噻二唑和1,2,4-三唑-5-硫酮衍生物:合成、分子对接、脲酶抑制及晶体结构
Arch Pharm (Weinheim). 2023 Jan;356(1):e2200355. doi: 10.1002/ardp.202200355. Epub 2022 Oct 31.

引用本文的文献

1
Thiourea-Derived Chelating Ligands and Their Organometallic Compounds: Investigations into Their Anticancer Activity.硫脲衍生螯合配体及其金属有机化合物:抗癌活性研究。
Molecules. 2020 Aug 11;25(16):3661. doi: 10.3390/molecules25163661.
2
Editorial of Special Issue Ruthenium Complex: The Expanding Chemistry of the Ruthenium Complexes.专题编辑:钌配合物:钌配合物不断扩展的化学性质
Molecules. 2015 Sep 18;20(9):17244-74. doi: 10.3390/molecules200917244.
3
Special issue: practical applications of metal complexes.特刊:金属配合物的实际应用

本文引用的文献

1
Synthesis and in vitro urease inhibitory activity of N,N'-disubstituted thioureas.N,N'-二取代硫脲的合成及其体外脲酶抑制活性
Eur J Med Chem. 2014 Mar 3;74:314-23. doi: 10.1016/j.ejmech.2014.01.001. Epub 2014 Jan 14.
2
Synthesis, molecular structure, computational study and in vitro anticancer activity of dinuclear thiolato-bridged pentamethylcyclopentadienyl Rh(III) and Ir(III) complexes.双核硫醇桥联茂金属铑(III)和铱(III)配合物的合成、分子结构、计算研究及体外抗癌活性。
Dalton Trans. 2013 Nov 21;42(43):15457-63. doi: 10.1039/c3dt51991k.
3
Exploration of the medical periodic table: towards new targets.
Molecules. 2015 Apr 30;20(5):7951-6. doi: 10.3390/molecules20057951.
医学元素周期表的探索:寻求新靶点。
Chem Commun (Camb). 2013 Jun 7;49(45):5106-31. doi: 10.1039/c3cc41143e.
4
Highly cytotoxic trithiophenolatodiruthenium complexes of the type [(η6-p-MeC6H4Pri)2Ru2(SC6H4-p-X)3]+: synthesis, molecular structure, electrochemistry, cytotoxicity, and glutathione oxidation potential.高细胞毒性三噻吩酚合二钌配合物[(η6-p-MeC6H4Pri)2Ru2(SC6H4-p-X)3]+:合成、分子结构、电化学、细胞毒性和谷胱甘肽氧化电位。
J Biol Inorg Chem. 2012 Aug;17(6):951-60. doi: 10.1007/s00775-012-0911-2. Epub 2012 Jun 16.
5
Protein crystal structures with ferrocene and ruthenocene-based enzyme inhibitors.含二茂铁基和钌茂基酶抑制剂的蛋白晶体结构。
Chem Commun (Camb). 2012 Feb 25;48(17):2328-30. doi: 10.1039/c2cc15625c. Epub 2012 Jan 18.
6
Synthesis, biological assay in vitro and molecular docking studies of new Schiff base derivatives as potential urease inhibitors.新型希夫碱衍生物的合成、体外生物活性测定及分子对接研究作为潜在的脲酶抑制剂。
Eur J Med Chem. 2011 Nov;46(11):5473-9. doi: 10.1016/j.ejmech.2011.09.009. Epub 2011 Sep 16.
7
Thiophenolato-bridged dinuclear arene ruthenium complexes: a new family of highly cytotoxic anticancer agents.噻吩醇桥联双核芳基金属钌配合物:一类新型高细胞毒性抗癌剂。
Dalton Trans. 2010 Nov 14;39(42):10305-13. doi: 10.1039/c0dt00887g. Epub 2010 Oct 4.
8
Synthesis and in vitro evaluation of substituted pyrimido[5,4-d]pyrimidines as a novel class of anti-Mycobacterium tuberculosis agents.合成及取代嘧啶并[5,4-d]嘧啶类化合物的体外评价作为新型抗结核分枝杆菌药物。
Eur J Med Chem. 2010 Jul;45(7):3234-9. doi: 10.1016/j.ejmech.2010.03.047. Epub 2010 Apr 3.
9
Synthesis, structures, and urease inhibitory activities of three copper(II) and zinc(II) complexes with 2-{[2-(2-hydroxyethylamino)ethylimino]methyl}-4-nitrophenol.三种含2-{[2-(2-羟乙基氨基)乙基亚氨基]甲基}-4-硝基苯酚的铜(II)和锌(II)配合物的合成、结构及脲酶抑制活性
Eur J Med Chem. 2010 Jul;45(7):3196-9. doi: 10.1016/j.ejmech.2010.03.012. Epub 2010 Mar 16.
10
Targeting proteins with metal complexes.用金属配合物靶向蛋白质。
Chem Commun (Camb). 2009 Mar 7(9):1001-10. doi: 10.1039/b813568a. Epub 2009 Jan 12.